Response to drug-eluting stent in-stent restenosis and re-restenosis: A hard time story.
出版信息
J Saudi Heart Assoc. 2017 Apr;29(2):75. doi: 10.1016/j.jsha.2016.12.002. Epub 2016 Dec 23.
Abstract
摘要
相似文献
1
Response to drug-eluting stent in-stent restenosis and re-restenosis: A hard time story.
J Saudi Heart Assoc. 2017 Apr;29(2):75. doi: 10.1016/j.jsha.2016.12.002. Epub 2016 Dec 23.
2
Drug-eluting stent in-stent restenosis and re-restenosis: A hard time story.
J Saudi Heart Assoc. 2017 Apr;29(2):73-74. doi: 10.1016/j.jsha.2016.12.001. Epub 2016 Dec 18.
3
Repeated sirolimus-eluting stent implantation to treat sirolimus-eluting stent and bare-metal stent restenosis.
Circ J. 2010 Nov;74(11):2329-33. doi: 10.1253/circj.cj-10-0210. Epub 2010 Sep 28.
4
Drug-eluting stents.
Arch Cardiol Mex. 2006 Jul-Sep;76(3):297-319.
5
New drug-eluting stents, optimizing technique, and the problem of drug-eluting stent restenosis.
Minerva Cardioangiol. 2005 Oct;53(5):341-60.
6
Optical coherence tomography (OCT) in PCI for in-stent restenosis (ISR): rationale and design of the SEDUCE (Safety and Efficacy of a Drug elUting balloon in Coronary artery rEstenosis) study.
EuroIntervention. 2011 May;7 Suppl K:K100-5. doi: 10.4244/EIJV7SKA17.
7
[Efficiency of endovascular re-interventions for evolving restenosis of different types of stents].
Vestn Rentgenol Radiol. 2012 Jan-Feb(1):21-7.
8
Differential impact of cilostazol on restenosis according to implanted stent type (from a pooled analysis of three DECLARE randomized trials).
Am J Cardiol. 2013 Nov 1;112(9):1328-34. doi: 10.1016/j.amjcard.2013.06.010. Epub 2013 Jul 24.
9
Comparison between catheter-based delivery of paclitaxel after bare-metal stenting and drug-eluting stents in coronary artery disease patients at high risk for in-stent restenosis.
Cardiovasc Revasc Med. 2017 Dec;18(8):596-600. doi: 10.1016/j.carrev.2017.05.018. Epub 2017 May 31.
10
Long-Term Efficacy and Safety of Paclitaxel-Eluting Balloon for the Treatment of Drug-Eluting Stent Restenosis: 3-Year Results of a Randomized Controlled Trial.
JACC Cardiovasc Interv. 2015 Jun;8(7):877-84. doi: 10.1016/j.jcin.2015.01.031. Epub 2015 May 20.
本文引用的文献
1
Drug-eluting stents or balloon angioplasty for drug-eluting stent-associated restenosis: An observational follow-up study of first-time versus repeated restenosis.
J Saudi Heart Assoc. 2017 Apr;29(2):76-83. doi: 10.1016/j.jsha.2016.10.001. Epub 2016 Oct 14.
2
Safety and efficacy of limus-eluting stents and balloon angioplasty for sirolimus-eluting in-stent restenosis.
Cardiovasc Revasc Med. 2015 Mar;16(2):84-9. doi: 10.1016/j.carrev.2015.01.004. Epub 2015 Jan 29.
3
Switching types of drug-eluting stents does not prevent repeated in-stent restenosis in patients with coronary drug-eluting stent restenosis.
Coron Artery Dis. 2014 Dec;25(8):638-44. doi: 10.1097/MCA.0000000000000159.
4
Implantation of a drug-eluting stent with a different drug (switch strategy) in patients with drug-eluting stent restenosis. Results from a prospective multicenter study (RIBS III [Restenosis Intra-Stent: Balloon Angioplasty Versus Drug-Eluting Stent]).
JACC Cardiovasc Interv. 2012 Jul;5(7):728-37. doi: 10.1016/j.jcin.2012.03.017.
Zotero 插件